Masataka Ikeda

2.3k total citations · 1 hit paper
57 papers, 1.7k citations indexed

About

Masataka Ikeda is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Masataka Ikeda has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Masataka Ikeda's work include Mitochondrial Function and Pathology (9 papers), Cardiovascular Function and Risk Factors (8 papers) and Cardiac Fibrosis and Remodeling (8 papers). Masataka Ikeda is often cited by papers focused on Mitochondrial Function and Pathology (9 papers), Cardiovascular Function and Risk Factors (8 papers) and Cardiac Fibrosis and Remodeling (8 papers). Masataka Ikeda collaborates with scholars based in Japan, United States and Finland. Masataka Ikeda's co-authors include Tomomi Ide, Hiroyuki Tsutsui, Shouji Matsushima, Tomonori Tadokoro, Ken‐ichi Yamada, Akihito Ishikita, Kosuke Okabe, Soichiro Ikeda, Tomoko Koumura and Hirotaka Imai and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Masataka Ikeda

53 papers receiving 1.6k citations

Hit Papers

Mitochondria-dependent ferroptosis plays a pivotal role i... 2020 2026 2022 2024 2020 100 200 300 400

Peers

Masataka Ikeda
Yassine Sassi United States
Ying Shen China
Can Hu China
Yassine Sassi United States
Masataka Ikeda
Citations per year, relative to Masataka Ikeda Masataka Ikeda (= 1×) peers Yassine Sassi

Countries citing papers authored by Masataka Ikeda

Since Specialization
Citations

This map shows the geographic impact of Masataka Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Ikeda more than expected).

Fields of papers citing papers by Masataka Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Ikeda. The network helps show where Masataka Ikeda may publish in the future.

Co-authorship network of co-authors of Masataka Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Ikeda. A scholar is included among the top collaborators of Masataka Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Ikeda. Masataka Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikeda, Masataka, Ko Abe, Satoshi Fujita, et al.. (2025). Excessive HIF-1α driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia. Nature Cardiovascular Research. 4(9). 1077–1093. 1 indexed citations
2.
Hata, Taishi, Hiroyuki Yamamoto, Masataka Ikeda, et al.. (2024). Status of perioperative venous thromboembolism (VTE) prophylaxis in gastrointestinal surgery based on national clinical database (NCD) data in Japan. Surgery Today. 55(6). 814–822.
3.
Kittaka, Hiroki, Kazuhito Gotoh, Yuichi Matsushima, et al.. (2024). iMPAQT reveals that adequate mitohormesis from TFAM overexpression leads to life extension in mice. Life Science Alliance. 7(7). e202302498–e202302498. 2 indexed citations
4.
Uchino, Motoi, et al.. (2024). The Impacts of Laparoscopic Restorative Proctocolectomy for Ulcerative Colitis: Systematic Review and Meta-Analysis. Inflammatory Intestinal Diseases. 9(1). 62–70.
5.
Imamura, Naoto, Masataka Ikeda, Tomomi Ide, et al.. (2024). Oxidized-LDL Induces Metabolic Dysfunction in Retinal Pigment Epithelial Cells. Biological and Pharmaceutical Bulletin. 47(3). 641–651. 2 indexed citations
6.
Watanabe, Tatsuya, Takeshi Tohyama, Masataka Ikeda, et al.. (2023). Development of deep-learning models for real-time anaerobic threshold and peak VO2 prediction during cardiopulmonary exercise testing. European Journal of Preventive Cardiology. 31(4). 448–457. 4 indexed citations
7.
Enzan, Nobuyuki, Shouji Matsushima, Soichiro Ikeda, et al.. (2023). ZBP1 Protects Against mtDNA-Induced Myocardial Inflammation in Failing Hearts. Circulation Research. 132(9). 1110–1126. 61 indexed citations
8.
Uchino, Motoi, Masataka Igeta, Kozo Kataoka, et al.. (2023). Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer. International Journal of Colorectal Disease. 38(1). 113–113. 1 indexed citations
9.
Ikeda, Masataka, Tomomi Ide, Shouji Matsushima, et al.. (2022). Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model. Circulation Heart Failure. 15(12). e009366–e009366. 14 indexed citations
10.
Abe, Ko, Masataka Ikeda, Tomomi Ide, et al.. (2022). Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis. Science Signaling. 15(758). eabn8017–eabn8017. 88 indexed citations
11.
Oh, Soo Jin, Masataka Ikeda, Tomomi Ide, Kyu Yeon Hur, & Myung‐Shik Lee. (2022). Mitochondrial event as an ultimate step in ferroptosis. Cell Death Discovery. 8(1). 414–414. 103 indexed citations
12.
Uchino, Motoi, Hiroki Ikeuchi, Tomohiro Minagawa, et al.. (2022). Association between preoperative biologic use and surgical morbidity in patients with Crohn’s disease. International Journal of Colorectal Disease. 37(5). 999–1010. 4 indexed citations
13.
Ikeda, Masataka, Tomomi Ide, Tomonori Tadokoro, et al.. (2021). Excessive Hypoxia‐Inducible Factor‐1α Expression Induces Cardiac Rupture via p53‐Dependent Apoptosis After Myocardial Infarction. Journal of the American Heart Association. 10(17). e020895–e020895. 26 indexed citations
14.
Ishikita, Akihito, Shouji Matsushima, Soichiro Ikeda, et al.. (2021). GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway. iScience. 24(12). 103517–103517. 18 indexed citations
15.
Tadokoro, Tomonori, Masataka Ikeda, Tomomi Ide, et al.. (2020). Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 5(9). 487 indexed citations breakdown →
16.
Ikeda, Soichiro, Shouji Matsushima, Kosuke Okabe, et al.. (2019). Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway. Scientific Reports. 9(1). 9850–9850. 43 indexed citations
17.
Ikeda, Masataka, et al.. (2016). Electron microscopy reveals morphosis of multi-layered mitochondria in the myocardium of a patient with mitochondrial cardiomyopathy. European Heart Journal. 37(17). 1372–1372. 4 indexed citations
18.
Ide, Tomomi, Yuko Kato, Kazuya Hosokawa, et al.. (2012). Isolated Pure Systolic Stress Upregulates Hypertrophy-related Genes, Whereas Isolated Diastolic Strain Upregulates Fibrosis-related Genes. Circulation. 76. 322. 3 indexed citations
19.
Sakamoto, Kazuo, Kazuya Hosokawa, Takeo Fujino, et al.. (2012). Abstract 16220: Baroreflex Failure Predisposes to Pulmonary Edema In Conscious Rats with Normal Left Ventricular Function. Circulation. 126(3). 753–771. 1 indexed citations
20.
Ogihara, Toshio, KAORU YOSHINAGA, Masataka Ikeda, et al.. (1991). Clinical Efficacy of Carvedilol in Severe Hypertension. Journal of Cardiovascular Pharmacology. 18. S69–S72. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026